MAPT and Parkinson disease: This was confirmed in patients with early PD vs. controls (n = 41, each group) especially in those at risk of developing early dementia, determined by microtubule-associated protein tau (MAPT) genotype and neuropsychological predictors (Williams-Gray et al., 2009).